MglA and igl proteins contribute to the modulation of Francisella tularensis live vaccine strain-containing phagosomes in murine macrophages

被引:100
作者
Bonquist, Linda [1 ]
Lindgren, Helena [1 ]
Golovliov, Igor [1 ]
Guina, Tina [2 ]
Sjostedt, Anders [1 ]
机构
[1] Umea Univ, Dept Clin Microbiol, SE-90185 Umea, Sweden
[2] Univ Washington, Dept Pediat, Div Infect Dis, Seattle, WA 98195 USA
基金
英国医学研究理事会;
关键词
D O I
10.1128/IAI.00226-08
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Francisella tularensis live vaccine strain (LVS), in contrast to its iglC mutant, replicates in the cytoplasm of macrophages. We studied the outcome of infection of the murine macrophagelike cell line J774A.1 with LVS and with iglC, iglD, and mgl4 mutants, the latter of which is deficient in a global regulator. Compared to LVS, all of the mutants showed impaired intracellular replication up to 72 h, and the number of the mgl4 mutant bacteria even decreased. Colocalization with LAMP-1 was significantly increased for all mutants compared to LVS, indicating an impaired ability to escape into the cytoplasm. A lysosomal acidity-dependent dye accumulated in approximately 40% of the vacuoles containing mutant bacteria but not at all in vacuoles containing LVS. Preactivation of the macrophages with gamma interferon inhibited the intracellular growth of all strains and significantly increased acidification of phagosomes containing the mutants, but it only slightly increased the LAMP-1 colocalization. The intracellular replication and phagosomal escape of the iglC and iglD mutants were restored by complementation in trans. In conclusion, the IglC, IglD, and MglA proteins each directly or indirectly critically contribute to the virulence of F. tularensis LVS, including its intracellular replication, cytoplasmic escape, and inhibition of acidification of the phagosomes.
引用
收藏
页码:3502 / 3510
页数:9
相关论文
共 32 条
  • [1] Survival and growth of Francisella tularensis in Acanthamoeba castellanii
    Abd, H
    Johansson, T
    Golovliov, I
    Sandström, G
    Forsman, M
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2003, 69 (01) : 600 - 606
  • [2] ANTHONY LSD, 1992, J IMMUNOL, V148, P1829
  • [3] Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages
    Balagopal, Ashwin
    MacFarlane, Amanda Shearer
    Mohapatra, Nrusingh
    Soni, Shilpa
    Gunn, John S.
    Schlesinger, Larry S.
    [J]. INFECTION AND IMMUNITY, 2006, 74 (09) : 5114 - 5125
  • [4] Identification of MglA-regulated genes reveals novel virulence factors in Francisella tularensis
    Brotcke, Anna
    Weiss, David S.
    Kim, Charles C.
    Chain, Patrick
    Malfatti, Stephanie
    Garcia, Emilio
    Monack, Denise M.
    [J]. INFECTION AND IMMUNITY, 2006, 74 (12) : 6642 - 6655
  • [5] Salmonella redirects phagosomal maturation
    Brumell, JH
    Grinstein, S
    [J]. CURRENT OPINION IN MICROBIOLOGY, 2004, 7 (01) : 78 - 84
  • [6] Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum
    Celli, J
    de Chastellier, C
    Franchini, DM
    Pizarro-Cerda, J
    Moreno, E
    Gorvel, AP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (04) : 545 - 556
  • [7] Autophagy-mediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replication
    Checroun, Claire
    Wehrly, Tara D.
    Fischer, Elizabeth R.
    Hayes, Stanley F.
    Celli, Jean
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (39) : 14578 - 14583
  • [8] Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages
    Clemens, DL
    Lee, BY
    Horwitz, MA
    [J]. INFECTION AND IMMUNITY, 2004, 72 (06) : 3204 - 3217
  • [9] Francisella tularensis enters macrophages via a novel process involving pseudopod loops
    Clemens, DL
    Lee, BY
    Horwitz, MA
    [J]. INFECTION AND IMMUNITY, 2005, 73 (09) : 5892 - 5902
  • [10] Conlan J Wayne, 2004, Expert Rev Vaccines, V3, P307